Documente Academic
Documente Profesional
Documente Cultură
colloidal nanocrystals has moved in the last few years from fundamental
and (iii) a motility assay based on the uptake of nanocrystals by living cells.
1143 (2003). Nanotechnology has solid commercial prospects, but the process of
converting basic discoveries into marketable products will be long and hard.
Nanotechnology has been showcased and revisited a number of times over the
past decade, with each pass hinting at the promise of a revolutionary, ubiquitous
technology. The editors of Sciencemagazine fell under its spell in 2001, when
Nature Biotechnology 21, 1144 - 1147 (2003).The current commercial path for
concerning the role of the US federal government and intellectual property (IP) in
T. Andrew Taton (2002) Dept of Chemistry, University of Minnesota, 207 Pleasant Street SE,
George M Whitesides (2003) “The 'right' size in nanobiotechnology” Nature Biotechnology 21,
1161 - 1165 (2003) Published online: 30 September 2003. The biological and
'small' depends on the application, but can range from 1 nm to 1 mm). A vigorous
trade across the borders of these areas of science is developing around new
materials and tools (largely from the physical sciences) and new phenomena
(largely from the biological sciences). The physical sciences offer tools for
synthesis and fabrication of devices for measuring the characteristics of cells and
REVIEW ARTICLE
Q A Pankhurst, J Connolly, S K Jones and J Dobson (2001) Vol. 301 no. 5641 pp. 1882-1884
from biology and biomedicine, the relevant physics of magnetic materials and
their responses to applied magnetic fields are surveyed. The way these properties
are controlled and used is illustrated with reference to (i) magnetic separation of
labelled cells and other biological entities; (ii) therapeutic drug, gene and
radionuclide delivery; (iii) radio frequency methods for the catabolism of tumours
via hyperthermia; and (iv) contrast enhancement agents for magnetic resonance
imaging applications.
Hao Yan1,Sung Ha Park,Gleb Finkelstein, John H. Reif and Thomas H. LaBean (2003)
with a square aspect ratio was designed and constructed. Programmable self-
assembly of 4 × 4 tiles resulted in two distinct lattice morphologies: uniform-
silver nanowires.
Kinneret Keren1, Rotem S. Berman1 and Evgeny Buchstab (1998) Department of Physics,
wall carbon nanotube as well as the template for the extended metallic wires
contacting it.
Marcel Bruchez Jr., Mario Moronne, Peter Gin, Shimon Weiss and A. Paul Alivisatos(1998)
September 1998: Vol. 285 no. 5387 pp. 2028-2030 Semiconductor nanocrystals
were prepared for use as fluorescent probes in biological staining and diagnostics.
nanocrystal probes are thus complementary and in some cases may be superior to
existing fluorophores.
Shaopeng Wang, Natalia Mamedova, Nicholas A. Kotov, Wei Chen, and Joe Studer (2002)
Nomadics Inc., 1024 S Innovation Way, Stillwater, Oklahoma 74074, Nano Letters, 2002, 2 (8),
pp 817–822 DOI: 10.1021/nl0255193 Publication Date (Web): July 19, 2002.Complementary
bioconjugates based on antibody−antigen interactions were synthesized from luminescent CdTe
nanoparticles (NPs). Antigen (bovine serum albumin) was conjugated to red-emitting CdTe NPs,
while green-emitting NPs were attached to the corresponding anti-BSA antibody (IgG). The NP
bioconjugates were characterized by native and SDS−PAGE electrophoresis, gel-permeation
HPLC, and circular dichroism. Antigen−antibody binding affinity was evaluated by enzyme-
linked immunosorbent assay (ELISA). The formation of BSA−IgG immunocomplex resulted in
the Förster resonance energy transfer (FRET) between the two different NPs: the luminescence
of green-emitting NPs was quenched whereas the emission of the red-emitting NPs was
enhanced. The luminescence recovered when the immunocomplex was exposed to an unlabeled
antigen. The immunocomplexes can be considered as a prototype of NP superstructures based on
biospecific ligands, while the competitive FRET inhibition can be used in an immunoassay
protocol.
Abstract
• Functionalized carbon nanotubes (CNTs) hold a lot of promise for application in
medicinal chemistry. Based on a method for preparation of water-soluble CNTs, we
covalently linked a neutralizing B cell epitope from the foot-and-mouth disease virus
(FMDV) to mono- and bis-derivatized CNTs. Immunological characterization of these
conjugates revealed that the epitope was appropriately presented after conjugation to
CNTs for recognition by antibodies as measured by BIAcore technology. Moreover,
peptide-carbon nanotubes elicited strong anti-peptide antibody responses in mice with no
detectable cross-reactivity to the carbon nanotubes. However, only the mono-derivitized
CNT conjugate induced high levels of virus-neutralizing antibodies. These findings
highlight for the first time the potential of CNTs to present biologically important
epitopes in an appropriate conformation both in vitro and in vivo and open up the
possibility for their use in vaccine delivery.
The BARC biosensor applied to the detection of biological warfare agents
Abstract
The Bead ARray Counter (BARC) is a multi-analyte biosensor that uses DNA hybridization,
magnetic microbeads, and giant magnetoresistive (GMR) sensors to detect and identify
biological warfare agents. The current prototype is a table-top instrument consisting of a
microfabricated chip (solid substrate) with an array of GMR sensors, a chip carrier board with
electronics for lock-in detection, a fluidics cell and cartridge, and an electromagnet. DNA probes
are patterned onto the solid substrate chip directly above the GMR sensors, and sample analyte
containing complementary DNA hybridizes with the probes on the surface. Labeled, micron-
sized magnetic beads are then injected that specifically bind to the sample DNA. A magnetic
field is applied, removing any beads that are not specifically bound to the surface. The beads
remaining on the surface are detected by the GMR sensors, and the intensity and location of the
signal indicate the concentration and identity of pathogens present in the sample. The current
BARC chip contains a 64-element sensor array, however, with recent advances in
magnetoresistive technology, chips with millions of these GMR sensors will soon be
commercially available, allowing simultaneous detection of thousands of analytes. Because each
GMR sensor is capable of detecting a single magnetic bead, in theory, the BARC biosensor
should be able to detect the presence of a single analyte molecule.
• REPORT
An ultrasensitive method for detecting protein analytes has been developed. The system
relies on magnetic microparticle probes with antibodies that specifically bind a target of
interest [prostate-specific antigen (PSA) in this case] and nanoparticle probes that are
encoded with DNA that is unique to the protein target of interest and antibodies that can
sandwich the target captured by the microparticle probes. Magnetic separation of the
complexed probes and target followed by dehybridization of the oligonucleotides on the
nanoparticle probe surface allows the determination of the presence of the target protein
by identifying the oligonucleotide sequence released from the nanoparticle probe. Because
the nanoparticle probe carries with it a large number of oligonucleotides per protein
binding event, there is substantial amplification and PSA can be detected at 30 attomolar
concentration. Alternatively, a polymerase chain reaction on the oligonucleotide bar codes
can boost the sensitivity to 3 attomolar. Comparable clinically accepted conventional assays
for detecting the same target have sensitivity limits of ∼3 picomdar, six orders of
magnitude less sensitive than what is observed with this method.
ArticleReferencesCited By
Cell Motility and Metastatic Potential Studies Based on Quantum Dot Imaging of
Phagokinetic Tracks
1. W.J. Parak1,
2. R. Boudreau3,
3. M. Le Gros4,
4. D. Gerion1,
5. D. Zanchet2,
6. C.M. Micheel2,
7. S.C. Williams2,
8. A.P. Alivisatos1,
9. C. Larabell3
Article first published online: 17 JUN 2002